Tradestie Institutional Equity Comparison Engine

ACRS vs LYRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACRS Overall Edge

ACRS Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aclaris Therapeutics, Inc. (ACRS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ACRS trades at N/M Forward P/E with -1412.4% operating margin (-55.1% YoY revenue) versus LYRA at N/M Forward P/E and -25032.0% operating margin (-87.2% YoY). In options structure, ACRS sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro) against LYRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ACRS N/M vs LYRA N/M Fwd P/E
Growth & Margin Winner ACRS
Op Margin -1412.4% vs -25032.0% ยท YoY -55.1% vs -87.2%
Momentum & Technical Winner ACRS
1Y +32.7% vs -94.3% ยท 52W Pos 25% vs 1%
Options & Structure Winner ACRS
BREAKDOWN (1st %ile IV) vs UNCLASSIFIED (N/A IV)
ACRS NASDAQ
Aclaris Therapeutics, Inc.
Pharmaceutical Preparations
$3.35
-7.21% 1D
Market Cap $621.8M
1M Return -3.88%
1Y Return +32.74%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 41.0 Fund 54.0 Flow 64.0 Mom 70.0
LYRA NASDAQ
Lyra Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.49
-62.5% 1D
Market Cap $2.3M
1M Return -62.5%
1Y Return -94.34%
Forward P/E N/M
Unified AI Score
52.2 / 100 HOLD
Tech 60.0 Fund 56.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACRS +32.74% LYRA -94.34% Spread: +135.55 pp (ACRS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ACRS Revenue LYRA Revenue ACRS Op. Margin LYRA Op. Margin Margin Edge
FY2018 $10M N/A -1378.3% N/A ACRS
FY2019 $0M N/A -2627.3% N/A ACRS
FY2020 $10M N/A -785.4% N/A ACRS
FY2021 $10M $0M -1327.1% -15303.5% ACRS
FY2022 $30M $0M -302.0% -4131.0% ACRS
FY2023 $30M $0M -311.6% -4308.1% ACRS
FY2024 $20M $0M -758.2% -6280.8% ACRS
FY2025 $10M $0M -975.9% -7794.5% ACRS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACRS (6) vs LYRA (1)
Institutional Metric ACRS LYRA Criterion Row Winner
Market Capitalization Scale $621.8M $2.3M Larger Scale ACRS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -55.1% -87.2% Higher Growth ACRS
Operating Margin (TTM) Profitability -1412.4% -25032.0% Higher Margin ACRS
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -55.5% -404.5% Higher ROE ACRS
52-Week Range Position Momentum 25% ($2โ€“$7) 1% ($0โ€“$38) Stronger Trend ACRS
Beta / 30D Volatility Risk Regime 1.56ฮฒ ยท 74% Vol 0.33ฮฒ ยท 248% Vol Lower Realized Risk ACRS
Unified Institutional Score Composite Signal 44.7 / 100 (HOLD) 52.2 / 100 (HOLD) Higher Composite LYRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACRS vs LYRA Buy Guide
ACRS BREAKDOWN
130d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 1st %ile
IV Regime Compressed (<25th %ile)
Live ACRS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LYRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LYRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACRS nor LYRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.